We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Pulls Ondansetron NDA, ANDAs Over Safety Concerns
FDA Pulls Ondansetron NDA, ANDAs Over Safety Concerns
The FDA is withdrawing approval of one NDA and four ANDAs for ondansetron, effective immediately, due to a potentially life-threatening complication with the drug.